Typicality: | 0.480 |
Saliency: | 0.236 |
ideally | 6 | degree |
through sexual contact | 6 | manner |
to the disease | 2 | other |
vaccine → be given before → exposure | 8 |
vaccine → be administered before → potential exposure | 6 |
vaccine → be administered before → infection | 3 |
negative | neutral | positive |
0.225 | 0.632 | 0.143 |
Raw frequency | 17 |
Normalized frequency | 0.236 |
Modifier score | 0.900 |
Perplexity | 53.800 |